Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Brainstorm Cell Therapeutics (BCLI) Other Operating Expenses (2014 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Other Operating Expenses of $114,000 in Q2 2026, down 53.5% from $245,000 a year earlier and down 56.5% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Other Operating Expenses (2014 - 2026) Analysis & Trends

On a TTM basis, Brainstorm Cell Therapeutics' Other Operating Expenses came in at $376,000 as of Jun 30, 2026, down 27.3% year-over-year; for FY2025, it came in at $947,000, down 24.8% from FY2024.

  • Across earlier years, Other Operating Expenses came in at $1.26 million in FY2024 (-31.9%) and $1.85 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Other Operating Expenses since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114,000.00
Mar 31, 2026 262,000.00
Jun 30, 2025 245,000.00
Mar 31, 2025 272,000.00
Dec 31, 2014 2,000.00
Sep 30, 2014 -2,000.00
API Access

Brainstorm Cell Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCLI&period=max&api_key=YOUR_API_KEY